SPDR S&P Biotech ETF $XBI Stock: GRIMES & Co WEALTH MANAGEMENT LLC Grows Stake

GRIMES & Co WEALTH MANAGEMENT LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 44.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 24,831 shares of the exchange traded fund’s stock after purchasing an additional 7,689 shares during the quarter. GRIMES & Co WEALTH MANAGEMENT LLC’s holdings in SPDR S&P Biotech ETF were worth $3,915,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of XBI. BOCHK Asset Management Ltd bought a new stake in SPDR S&P Biotech ETF during the third quarter worth about $552,000. Signature Equity Partners LLC increased its holdings in SPDR S&P Biotech ETF by 1,285.7% in the 3rd quarter. Signature Equity Partners LLC now owns 194 shares of the exchange traded fund’s stock valued at $31,000 after buying an additional 180 shares during the period. Vigilare Wealth Management bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $1,014,000. Trek Financial LLC raised its position in shares of SPDR S&P Biotech ETF by 105.5% in the 3rd quarter. Trek Financial LLC now owns 80,717 shares of the exchange traded fund’s stock valued at $12,727,000 after buying an additional 41,441 shares in the last quarter. Finally, Bank Julius Baer & Co. Ltd Zurich raised its position in shares of SPDR S&P Biotech ETF by 6.4% in the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 29,480 shares of the exchange traded fund’s stock valued at $4,648,000 after buying an additional 1,786 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.9%

Shares of SPDR S&P Biotech ETF stock opened at $154.97 on Wednesday. The company has a market cap of $10.57 billion, a PE ratio of 11.47 and a beta of 0.87. The company has a 50 day moving average of $156.14 and a 200-day moving average of $141.86. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.